Patient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.
by Marcus A. Banks
From the Editor-in-Chief
Paying attention to the social determinants of health will promote greater equity in cancer outcomes for all.
by William G. Nelson, MD, PhD
Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.
by Kendall K. Morgan
The Clinical Treatment Act aims to include more Medicaid recipients.
by Jen Tota McGivney
Awareness of the link between cancer risk and a diet lacking fruits and vegetables has been declining.
by Carisa D. Brewster
Fear of discrimination may lead to lower screening rates.
by Tara Santora
A therapeutic vaccine targeting advanced cervical cancer.
by Anna Azvolinsky
Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients.
by Sharon Tregaskis
Facts and Stats
The advent of checkpoint inhibitors has broadened the range of cancer patients able to take advantage of immunotherapy.
by Bradley Jones
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker.
by Rob Weker
Patient advocates learned about COVID-19 and cancer in an AACR virtual forum.
by Kevin McLaughlin
To gain control over fear of my breast cancer recurring, I called on lessons learned as a 5-year-old confronting the neighborhood bully.
by Joan Harris
Although there are many factors that can increase the risk for prostate cancer, for a significant number of men it can be inherited.
The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.
The majority of patients’ cancers don't respond to immune checkpoint inhibition. The reasons for this resistance remain unclear.
Handle With Care
donate to the AACR